A study from the EuroSpA collaboration validates new BASDAI cut-offs for disease activity in axial spondyloarthritis bas
Tweet Content
A study from the EuroSpA collaboration validates new BASDAI cut-offs for disease activity in axial spondyloarthritis based in ASDAS: <1.4 for remission, <2.8 for low activity, and >5.9 for very high activity. This research enhances our understanding of disease states and their… https://t.co/OkPiTwSHz6 https://t.co/NjIDeme9dm
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off